ROCKWELL MEDICAL, INC.
Pharmaceutical Preparations · WIXOM · MI
Moderate confidence (50%)
Updated Oct 19, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: ROCKWELL MEDICAL, INC. received a delisting notice from its exchange (May 8, 2026)
Timeline
Every material event, newest first. History is never overwritten.
ROCKWELL MEDICAL, INC. received a delisting notice from its exchange
May 8, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 8, 2026, Rockwell Medical, Inc. (the Company ) received written notice (the Notice ) from the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities maintain a minimum closing bid price of $1.00 per share (the Minimum Bid Price Requirement ), and Listing Ru…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker RMTI on Nasdaq.
- SEC CIK
- 0001041024
- Website
- —
- —
- Headquarters
- WIXOM, MI
- Also known as
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Legal entities
- ROCKWELL MEDICAL, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
ROCKWELL MEDICAL, INC. — Pharmaceutical Preparations (SIC 2834) — WIXOM, MI
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 8, 2026, Rockwell Medical, Inc. (the Company ) received written notice (the Notice ) from the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities maintain a minimum closing bid price of $1.00 per share (the Minimum Bid Price Requirement ), and Listing Ru…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:44 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:39 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.